10 Tips to Combat Coronavirus 10 Tips to Combat Coronavirus

ADVERTISEMENT

Reversing Alzheimer's With Light Therapy

Analysis by Dr. Joseph Mercola Fact Checked

Story at-a-glance -

  • A trial is underway using a headset with light-emitting diodes (LEDs) to shine light into the brain via the nose and skull in patients with Alzheimer’s disease
  • Early results showed patients regained memory and reading and writing skills after three months of treatment, leading to the launch of a 12-week trial
  • The headset, known as Neuro RX Gamma, uses near infrared pulsed at gamma frequency into the brain region known as the hippocampus, which controls memory
  • In the early trial, dementia patients had improved cognitive function and sleep as well as reduced anxiety, wandering and angry outbursts, with no negative side effects
  • Photobiomodulation works, in part, by boosting mitochondria, the powerhouse of your cells, which in turn stimulates microglia, or immune cells, in the brain, helping to ward off the disease

In the U.S., 5.8 million Americans aged 65 years and older have Alzheimer’s disease, and this number is expected to jump to about 14 million by 2050. Every 65 seconds, someone in the U.S. is diagnosed with the disease, which has no known cure and limited treatments to help manage symptoms.

While conventional medicine has focused on drugs to treat symptoms, most have only limited effectiveness. Alzheimer’s has steadily ranked as the sixth leading cause of death in the U.S., but some estimates suggest Alzheimer’s deaths may be underreported, possibly making it the third leading cause of death for older people.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access